Treating cancer

Evolving how cancer is treated

As a leading cause of death worldwide, cancer accounts for almost 10 million deaths annually.1,2 We are leveraging innovations in oncology drug development to expand our horizons for what is possible. We pursue areas of significant unmet need, striving to transform science into new treatment strategies for patients who need them most.

Maximizing impact with innovative treatment modalities

Woman looking into the distance

We work across the drug development life cycle to optimize medicines for the patients we serve. Our industry-leading translational medicine practices help ensure every patient may have access to an appropriate therapy.


Our medicines have been key drivers of our growth for the past decade. And our goal has always been to maximize the use of our treatments across different forms of cancer and therapy settings. 

Access to investigational therapies

We believe all patients should have access to our investigational medicines when it is appropriate.

We are tireless in advancing our science

Scientist in lab smiling at camera

I am energized by scientific learnings that lead to understanding, and I’m excited to work with my team to bring the next generation of Exelixis medicines to patients.

Heather Finlay

Vice President, Medical Chemistry

1 Sung, H., Ferlay, J., Siegel, R.L., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249.

2 Cancer Today GLOBOCAN 2022: All Cancers. Global Cancer Observatory website. Available at: Accessed March 2024.

You are now leaving the website. This link will take you to a website to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website.